viimane versioon :
22/08/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Mercaptopurine
keemiline struktuur
Viited : Mercaptopurine
tüüp
avaldamine
2396
ajaleht
Aliabadi HM, Romanick M, Desai S, Lavasanifar A.
Effect of buffer and antioxidant on stability of a mercaptopurine suspension
Am J Health-Syst Pharm 2008 ; 65: 441-447.
3244
plakat
Sutra C, Guillemot C, Monnier S, Puiset F, Canonge JM.
Stabilité chimique et microbiologique d'une suspension de mercaptopurine à 5 mg/mL.
SFPO Congress Mandelieu, France 2011
3843
ajaleht
Peacock G.F, Sauvageot J, Hill A, Killian A.
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Int J Pharm Compound 2016 ; 20, 1: 81-85
4177
ajaleht
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526
Mentions Légales